AI Buyer Insights:

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

List of InteleGence Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
Integrum Distribution 20 $2M Sweden Intelerad Medical Systems InteleGence Clinical Trial Management 2025 n/a
In 2025 Integrum implemented InteleGence as a Clinical Trial Management application to enable secure CT imaging upload and sharing across Sweden and the United States, supporting surgical planning and clinical research networks in life sciences and clinical research workflows. The deployment is tied to a partnership with Intelerad Medical Systems and leverages InteleShare cloud PACS capabilities for image transport and repository functions to support cross-site image access and collaboration. The implementation emphasized imaging ingestion and cloud PACS storage, secure DICOM handling, study level metadata tagging, role based access controls and collaborative study workspaces to align surgical planning workflows with clinical research needs. InteleGence was configured to manage image-centric study datasets and provide controlled sharing and viewing for surgical teams and research collaborators. Integrations include direct use of Intelerad InteleShare Cloud PACS for CT image upload and sharing between Integrum clinical sites in Sweden and research partners in the United States, and connectivity was established at the study and imaging series level to enable coordinated review and planning. Operational coverage spans surgical teams and participating clinical research network sites, with data orchestration focused on secure transfer and study level access management. Governance and rollout were structured around centralized access policies, audit logging and phased onboarding of surgical and research users, with Integrum working alongside Intelerad for operational support and system configuration. The stated objective of the InteleGence deployment is to streamline surgical planning and enhance patient outcomes while enabling image sharing across clinical research networks.
UC Health Healthcare 12000 $3.0B United States Intelerad Medical Systems InteleGence Clinical Trial Management 2024 n/a
In 2024, UC Health implemented InteleGence within a Clinical Trial Management initiative supported by vendor Intelerad Medical Systems. The deployment was aligned with an academic research cloud PACS implementation referenced as InteleShare Research, focusing on automating secure upload, anonymization, and centralized management of imaging for multi site clinical trials at the University of Cincinnati Medical Center. The implementation centered on imaging ingestion and study lifecycle capabilities typical of Clinical Trial Management, including automated secure upload pipelines, automated anonymization workflows, and a centralized imaging repository for protocol driven access. InteleGence was configured to support study level tagging, controlled user access, and imaging quality control processes to ensure consistent handling of trial imaging across sites. Operational coverage targeted clinical research and radiology functions supporting multi site trial workflows within the United States, with the academic research cloud PACS acting as the central store for imaging assets. Integrations were limited to internal imaging workflows and anonymization processes described in the case context, with no external system integrations specified in source material. Governance focused on study specific access controls and anonymization policies to enforce privacy and protocol compliance, with Intelerad and institutional research teams coordinating rollout and operational handoff. The narrative emphasizes standardized imaging management and automated anonymization as core capabilities introduced by InteleGence in this Clinical Trial Management deployment.
Vision Xray Group Australia Healthcare 120 $15M Australia Intelerad Medical Systems InteleGence Clinical Trial Management 2024 n/a
In 2024, Vision Xray Group Australia integrated Intelerad’s InteleGence into their radiology imaging stack, connecting the AI platform to their existing InteleViewer instance to support fracture detection workflows. The deployment was executed for a radiology imaging use case in Australia and the implementation is recorded under the Clinical Trial Management category while functionally serving diagnostic imaging and reading efficiency objectives. The InteleGence implementation centered on an AI-driven fracture detection capability, configured to run inference on exam images within InteleViewer and to surface visual overlays and priority flags in the reader workflow. Functional components implemented included automated image analysis, case prioritization for expedited reads, and result annotations to augment reporting and clinician decision support. Integration scope was limited to the radiology department and the InteleViewer environment inside Vision Xray Group Australia, aligning AI outputs with routine reading and reporting workflows. Governance changes focused on embedding the AI alerts into existing clinician triage and read sequences, and operational rollout emphasized live case flagging rather than batch processes. The customer reported increased diagnostic quality and reading efficiency following the InteleGence integration, reflecting improved clinical support within their radiology operations.
Showing 1 to 3 of 3 entries

Buyer Intent: Companies Evaluating InteleGence

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating InteleGence. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD InteleGence Coverage

InteleGence is a Clinical Trial Management solution from Intelerad Medical Systems.

Companies worldwide use InteleGence, from small firms to large enterprises across 21+ industries.

Organizations such as UC Health, Vision Xray Group Australia and Integrum are recorded users of InteleGence for Clinical Trial Management.

Companies using InteleGence are most concentrated in Healthcare and Distribution, with adoption spanning over 21 industries.

Companies using InteleGence are most concentrated in United States, Australia and Sweden, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of InteleGence across Americas, EMEA, and APAC.

Companies using InteleGence range from small businesses with 0-100 employees - 33.33%, to mid-sized firms with 101-1,000 employees - 33.33%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 33.33%.

Customers of InteleGence include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified InteleGence customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Clinical Trial Management.